UA93209C2 - Комбинация снотворного агента продолжительного действия эпливансерина и снотворного агента короткого действия золпидема - Google Patents

Комбинация снотворного агента продолжительного действия эпливансерина и снотворного агента короткого действия золпидема

Info

Publication number
UA93209C2
UA93209C2 UAA200803488A UAA200803488A UA93209C2 UA 93209 C2 UA93209 C2 UA 93209C2 UA A200803488 A UAA200803488 A UA A200803488A UA A200803488 A UAA200803488 A UA A200803488A UA 93209 C2 UA93209 C2 UA 93209C2
Authority
UA
Ukraine
Prior art keywords
hypnotic agent
acting hypnotic
combination
short
long
Prior art date
Application number
UAA200803488A
Other languages
English (en)
Ukrainian (uk)
Inventor
Ален Кюин
Мишель Декобер
Доминик Франкон
Анри Сональ
Original Assignee
Санофи-Авентис
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи-Авентис filed Critical Санофи-Авентис
Publication of UA93209C2 publication Critical patent/UA93209C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение касается комбинации, по меньшей мере, одного снотворного агента короткого действия, который представляет собой золпидем, с по меньшей мере, одним снотворным агентом продолжительного действия, который представляет собой эпливансерин, и его применения для лечения расстройств сна.
UAA200803488A 2005-08-19 2006-07-27 Комбинация снотворного агента продолжительного действия эпливансерина и снотворного агента короткого действия золпидема UA93209C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0508643A FR2889811B1 (fr) 2005-08-19 2005-08-19 Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique.

Publications (1)

Publication Number Publication Date
UA93209C2 true UA93209C2 (ru) 2011-01-25

Family

ID=36273351

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200803488A UA93209C2 (ru) 2005-08-19 2006-07-27 Комбинация снотворного агента продолжительного действия эпливансерина и снотворного агента короткого действия золпидема

Country Status (26)

Country Link
US (2) US20080181943A1 (ru)
EP (1) EP1919473B1 (ru)
JP (1) JP5215851B2 (ru)
KR (1) KR20080039909A (ru)
CN (1) CN101267819B (ru)
AR (1) AR055123A1 (ru)
AU (1) AU2006281334B2 (ru)
BR (1) BRPI0614792A2 (ru)
CA (1) CA2618212C (ru)
CR (1) CR9695A (ru)
EA (1) EA014294B1 (ru)
EC (1) ECSP088131A (ru)
FR (1) FR2889811B1 (ru)
HK (1) HK1124541A1 (ru)
HN (1) HN2008000278A (ru)
IL (1) IL188823A0 (ru)
MA (1) MA29766B1 (ru)
MX (1) MX2008002275A (ru)
NO (1) NO20081250L (ru)
NZ (1) NZ565880A (ru)
SG (1) SG165316A1 (ru)
TN (1) TNSN08027A1 (ru)
TW (1) TW200738238A (ru)
UA (1) UA93209C2 (ru)
WO (1) WO2007020337A1 (ru)
ZA (1) ZA200800968B (ru)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200626137A (en) * 2004-12-13 2006-08-01 Takeda Pharmaceuticals Co Preventive or therapeutic agent for sleep disorder
WO2009084023A2 (en) * 2007-10-19 2009-07-09 Glenmark Generics Limited Amorphous ramelteon and process for the preparation thereof
WO2009082268A2 (ru) 2007-12-21 2009-07-02 Alla Chem, Llc ЛИГАНДЫ α-АДРЕНОЦЕПТОРОВ, ДОПАМИНОВЫХ, ГИСТАМИНОВЫХ, ИМИДАЗОЛИНОВЫХ И СЕРОТОНИНОВЫХ РЕЦЕПТОРОВ И ИХ ПРИМЕНЕНИЕ
EP2365805A1 (en) * 2008-11-13 2011-09-21 Sanofi Method of treating sleep disorders using eplivanserin
FR2938534B1 (fr) 2008-11-14 2012-10-26 Sanofi Aventis Procede de preparation de l'hemifumarate d'eplivanserine
WO2010065547A1 (en) * 2008-12-01 2010-06-10 Map Pharmaceuticals, Inc. Inhalation delivery methods and devices
US8555875B2 (en) * 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
AU2010213678B2 (en) 2009-02-13 2015-11-26 Romark Laboratories L.C. Controlled release pharmaceutical formulations of nitazoxanide
EP2255807A1 (en) * 2009-05-26 2010-12-01 Sanofi-Aventis Method of treating sleep disorders using the combination of eplivanserin and zolpidem
EP2255726A1 (en) * 2009-05-26 2010-12-01 Sanofi-Aventis Spectral profile of SWS enhancing drugs
WO2012109695A1 (en) * 2011-02-16 2012-08-23 Casal Y Galzov Ramon Ernesto Drug compositions for the treatment of insomnia
WO2012170883A1 (en) 2011-06-09 2012-12-13 Discovery Pharma Consulting, Llc Antihistamines combined with dietary supplements for improved health
CN102579383A (zh) * 2012-04-09 2012-07-18 南京正科制药有限公司 右佐匹克隆缓释片
SG10202004858TA (en) * 2014-02-06 2020-06-29 Lan Bo Chen Composition and method for aiding sleep
CN108289849A (zh) 2015-06-26 2018-07-17 韩国联合制药株式会社 莫沙必利与雷贝拉唑的复合制剂
CN105596313B (zh) * 2016-02-17 2018-06-29 新乡医学院第一附属医院 一种具有反向药理功能的用于治疗失眠的胶囊制剂
CN105997958B (zh) * 2016-07-12 2019-03-26 中国人民解放军白求恩医务士官学校 一种口腔外用制剂及其制备方法
JP6830156B2 (ja) * 2016-10-31 2021-02-17 ニューリム・ファーマシューティカルズ・リミテッドＮｅｕｒｉｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． メラトニンミニタブレットおよびその製造方法
WO2018121758A1 (zh) * 2016-12-30 2018-07-05 南京明德新药研发股份有限公司 作为egfr抑制的喹唑啉类化合物
CN111670050A (zh) 2018-01-30 2020-09-15 爱普宁公司(特拉华) 用于治疗睡眠呼吸暂停的方法和组合物
CN113395962A (zh) 2018-11-21 2021-09-14 Certego治疗公司 加波沙朵用于降低自杀风险和快速缓解抑郁症
US20220096401A1 (en) * 2019-02-08 2022-03-31 The Brigham And Women's Hospital, Inc. Methods and compositions for treating sleep apnea
KR20230028244A (ko) 2020-05-20 2023-02-28 썰테고 테라퓨틱스 아이엔씨. 고리 중수소화 가복사돌 및 정신 장애의 치료를 위한 이의 용도
FR3116439B1 (fr) * 2020-11-26 2023-08-04 Laboratoire Dielen Comprimé pelliculé contenant au moins un principe actif, adapté à l’administration par voie orale dudit au moins un principe actif chez des sujets humains
CN115919806A (zh) * 2022-12-22 2023-04-07 南京乐韬生物科技有限公司 一种gaba缓释胶囊的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3509637B2 (ja) * 1998-06-09 2004-03-22 武田薬品工業株式会社 睡眠障害予防治療剤
ATE247967T1 (de) * 1998-06-09 2003-09-15 Takeda Chemical Industries Ltd Pharmazeutische kombination mit einem trizyclischen komponent und mindestens einem aus zolpidem, zopiclone und brotizolam, zur behandlung von schlafstörungen
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
DK1691811T3 (da) * 2003-12-11 2014-10-20 Sunovion Pharmaceuticals Inc Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression
WO2005063297A2 (en) * 2003-12-24 2005-07-14 Sepracor Inc. Melatonin combination therapy for improving sleep quality
TW200626137A (en) * 2004-12-13 2006-08-01 Takeda Pharmaceuticals Co Preventive or therapeutic agent for sleep disorder
CN101257907A (zh) * 2005-07-06 2008-09-03 塞普拉科公司 左旋佐匹克隆和抗抑郁剂的组合
RU2008110498A (ru) * 2005-08-19 2009-09-27 Авентис Фармасьютикалз Инк. (Us) Комбинация снотворного средства и замещенного соединения бис арила и гетероарила и ее терапевтическое применение
RU2008110477A (ru) * 2005-08-19 2009-09-27 Авентис Фармасьютикалз Инк. (Us) Комбинация снотворного и r (+)-а-(2, 3-диметоксифенил)-1-[2-(4-фторфенил)этил]-4-пиперидинметанола и его терапевтическое применение

Also Published As

Publication number Publication date
CN101267819B (zh) 2012-05-30
TNSN08027A1 (en) 2009-07-14
NZ565880A (en) 2011-07-29
FR2889811B1 (fr) 2009-10-09
CN101267819A (zh) 2008-09-17
IL188823A0 (en) 2008-12-29
CA2618212A1 (fr) 2007-02-22
EA200800618A1 (ru) 2008-06-30
SG165316A1 (en) 2010-10-28
NO20081250L (no) 2008-05-13
AU2006281334B2 (en) 2012-10-18
BRPI0614792A2 (pt) 2011-04-12
ECSP088131A (es) 2008-02-20
EP1919473B1 (fr) 2012-12-05
HN2008000278A (es) 2011-03-30
CA2618212C (fr) 2014-03-25
US20080181943A1 (en) 2008-07-31
US20100291204A1 (en) 2010-11-18
AR055123A1 (es) 2007-08-08
JP5215851B2 (ja) 2013-06-19
EA014294B1 (ru) 2010-10-29
HK1124541A1 (en) 2009-07-17
MA29766B1 (fr) 2008-09-01
JP2009504713A (ja) 2009-02-05
TW200738238A (en) 2007-10-16
ZA200800968B (en) 2009-04-29
FR2889811A1 (fr) 2007-02-23
CR9695A (es) 2008-02-20
MX2008002275A (es) 2008-03-27
KR20080039909A (ko) 2008-05-07
WO2007020337A1 (fr) 2007-02-22
EP1919473A1 (fr) 2008-05-14
AU2006281334A1 (en) 2007-02-22

Similar Documents

Publication Publication Date Title
UA93209C2 (ru) Комбинация снотворного агента продолжительного действия эпливансерина и снотворного агента короткого действия золпидема
SV2005002148A (es) &#34;compuestos moduladores de la actividad c-kit y usos de los mismos&#34;
NZ548954A (en) Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
MXPA05013733A (es) 2-aminobenzotiazoles como agonistas inversos del receptor de cb1.
IL184932A0 (en) Glucagon receptor antagonists, preperation and therapeutic uses
BRPI0418092A (pt) combinação terapêutica para melhora cognitiva e transtornos psicóticos
MY161834A (en) Substituted diazepan compounds as orexin receptor antagonists
HK1066534A1 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
IL181700A0 (en) Quinazoline derivatives and pharmaceutical compositions containing the same
BRPI0517438A (pt) composto, método para tratar a condição associada com atividade de receptor muscarìnico m4, uso do composto, e, composição farmacêutica
NO20034122D0 (no) Sammensmeltede pyridinderivater for anvendelse som vanilloidreseptorantagonister for behandling av smerte
ECSP067082A (es) Antagonistas de receptor de glucagon, preparacion y usos terapeuticos
WO2007025005A3 (en) Sustained release formulations of nalbuphine
EA200970302A1 (ru) Тиофенпиразолопиримидиновые соединения
BR0314488A (pt) Composto, composição farmacêutica e métodos de tratamento
BR0104834A (pt) Moduladores de receptores de glucocorticóides
AU2003270199A1 (en) Urea compounds active as vanilloid receptor antagonists for the treatment of pain
IL179206A0 (en) Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same
IL188942A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
ATE327974T1 (de) Modulatoren des glucocorticoid-rezeptors
MA32639B1 (fr) [4-(5-aminométhyl-2-fluoro-phényl)-pipéridin- 1-yl]-[7-fluoro-1- (2-méthoxy-éthyl)-4-trifluorométhoxy-1h-indol-3-yl]-méthanone en tant qu&#39;inhibiteur de la tryptase de mastocytes
MX2007003545A (es) Composiciones y metodos para tratar trastornos cognitivos.
UA83868C2 (ru) Производные бензимидазолона и хиназолинона в качестве агонистов человеческих рецепторов orl1
TW200519102A (en) Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
MY148488A (en) Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists